Glenview Trust CO Albemarle Corp Transaction History

Glenview Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$162.63 - $243.44 $89,283 - $133,648	-549 Reduced 27.91%	1,418 $241,000
Q2 2023 Aug 14, 2023	SELL	$172.91 - $232.22 $5,706 - $7,663	-33 Reduced 1.65%	1,967 $438,000
Q1 2023 May 09, 2023	BUY	$208.49 - $290.15 $45,867 - $63,832	220 Added 12.36%	2,000 $442,000
Q3 2022 Nov 04, 2022	SELL	$195.82 - $307.05 $29,373 - $46,057	-150 Reduced 7.77%	1,780 $471,000
Q2 2022 Aug 10, 2022	BUY	$187.76 - $270.92 $18,776 - $27,092	100 Added 5.46%	1,930 $403,000
Q1 2022 May 11, 2022	BUY	$172.09 - $246.0 $30,976 - $44,280	180 Added 10.91%	1,830 $405,000
Q3 2021 Nov 12, 2021	BUY	$167.91 - $244.03 $277,051 - $402,649	1,650 New	1,650 $361,000

928

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.6B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Glenview Trust CO, based on Form 13F filings with the SEC.

Stay updated on Glenview Trust CO with notifications on news.